Yohai Stenzler

CFO

Equibles does not estimate personal net worth.

Get an email with a short summary when EoCene Ltd. publishes a filing, an earnings call transcript or a press release.

About Yohai Stenzler

Yohai Stenzler is recorded as CFO at EoCene Ltd. (EOCN). Yohai Stenzler has spoken on 7 earnings calls across 1 company, most recently for EoCene Ltd. on December 31, 2021. EoCene Ltd. is classified in the Biotechnology industry within the Healthcare sector.

Yohai Stenzler on recent calls

“This morning I will be providing you with our financial results for the fourth quarter and year ended December 31, 2021. For more information, please refer to our important Form 20-F filed earlier today with the SEC, which among other things provides a summary of such financial results.”

Chief Accounting Officer, Galmed Pharmaceuticals Ltd. Q4 FY2021 Earnings Call · December 31, 2021

“This morning, I will be providing you with our financial results for the third quarter ended September 30, 2021. For more information, please refer to our Form 6-K filed earlier today with the SEC which, among other things, provides a summary of such financial results.”

CFO, Galmed Pharmaceuticals Ltd. Q3 FY2021 Earnings Call · November 8, 2021

“This morning, I will be providing you with our financial results for the second quarter ended June 30, 2021. For more information, please refer to our report on Form 6-K filed earlier today with the SEC which, among other things, provides a summary of such financial results.”

CFO, Galmed Pharmaceuticals Ltd. Q2 FY2021 Earnings Call · August 5, 2021

“Joining today this morning, I will be providing you with our financial results for the quarter ended March 31st, 2021. For more information, please refer to our Form 6-K primarily filed with the SEC, which among other things provides a summary of such financial results.”

CFO, Galmed Pharmaceuticals Ltd. Q1 FY2021 Earnings Call · May 13, 2021

“This morning, I will be providing you with our financial results for the fourth quarter and year ended December 31, 2020. For more information, please refer to our report on Form 20-F filed earlier today with the SEC, which among other things provides a summary of such financial results.”

CFO, Galmed Pharmaceuticals Ltd. Q4 FY2020 Earnings Call · March 18, 2021